- Product Partners
- Supplements Facts
- Scientific References
- Client Reviews
Boost Tooth and Gum Health, Improve Bad Breath –
And Support Ear, Nose and Throat Health Too
You likely know the many benefits of probiotic bacteria in the intestines - now you can get the benefit of probiotic bacteria in your mouth and throat areas too.
The TrueOC™ Quick Melt contains BLIS K12® and BLIS M18®, two clinically studied strains of the naturally occurring probiotic organism Streptococcus salivarius.
These oral probiotics were discovered by Professor John Tagg, a microbiologist at the University of Otaga in New Zealand.
Professor Tagg was curious why certain people aren’t as susceptible to oral health problems - such as cavities, bleeding gums, upper respiratory illness - as most of the population. He discovered the answer: about 2% of humans are able to naturally produce protective Streptococcus salivarius organisms in their mouth.
The rest of us need to supplement these beneficial bacteria - and now you can with the TrueOC™ Quick Melt - a natural peppermint flavored lozenge that dissolves in your mouth in about 90 seconds.
When taken regularly, these specific probiotic strains have been shown to support several aspects of tooth and gum health and protect against the overgrowth of bacteria that causes bad breath. BLIS® K12 and BLIS® M18 do this by colonizing in the mouth and throat.
In clinical studies, BLIS® K12 has been shown to stimulate the immune system to improve upper respiratory (ear, nose, throat) health and reduce bad breath - in children and adults.
BLIS® M18 works more directly on dental health - helping to reduce the overgrowth of bacteria that increases cavity risk, supporting reduced plaque formation and helping to maintain tooth enamel by neutralizing acid.
ACTIValoe® is included because recent studies have shown that in the oral cavity, aloe vera promotes gum health by helping to reduce dental plaque and soothing gums.
For best results, if you use an anti-microbial mouthwash, take the TrueOC™ Quick Melt at least three hours after rinsing with your mouthwash.
BLIS® K12 and BLIS® M18: Promoting a
Dietary Supplement / 30 Vegetarian Capsules
Serving Size: 1 Lozenge
Servings per Container: 30
|Amount Per Serving|
|BLIS® K12 Streptococcus salivarius||2 billion CFU*†|
|BLIS® M18 Streptococcus salivarius||2 billion CFU*†|
|ACTIValoe® Aloe vera inner leaf gel||50 mg*†|
* Daily value not established.
Other ingredients: F-MELT® blend (mannitol, xylitol, microcrystalline cellulose, crospovidone, dicalcium phosphate), natural flavors, vegetable magnesium stearate and silica.
Contains milk derivatives.
‡ Minimum CFU count at time of manufacture.
BLIS® M18 and BLIS® K12 are the trademarks of Blis Technologies Limited and used with their permission and under a license granted by them.
ACTIValoe® is a registered trademark of Aloecorp, Inc.
F-MELT® is a registered trademark of Fuji Health Science, Inc.
Suggested Use: Take one (1) lozenge per day. Allow lozenge to dissolve completely by swirling around mouth. For additional oral care support, a second lozenge can be taken at a separate time of day.
TrueOC™ contains BLIS® K12 and BLIS® M18 which are two clinically studied strains of the naturally occurring probiotic organism Streptococcus salivarius.
When taken regularly, these specific probiotic strains have been shown to support several aspects of tooth and gum health and protect against the overgrowth of bacteria that causes bad breath. In addition, BLIS® K12 and BLIS® M18 have been shown to promote upper respiratory, ear and throat health.†
ACTIValoe® aloe vera provides additional support for tooth and gum health.†
Keep out of reach of children.
Store at 15-30° C (59-86° F).
Protect from heat, light and moisture.
Do not purchase if seal is broken.
†These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
- Gluten Free
- Assembled in the USA
Manufactured for and Distributed by: NatureCity®
Boca Raton, FL 33487 www.naturecity.com
To re-order call toll free 1-800-593-2563
TrueOC Quick Melt
Di Pierro F, Di Pasquale D, Di Cicco M. “Oral use of Streptococcus salivarius K12 in children with secretory otitis media: preliminary results of a pilot, uncontrolled study.” International Journal of General Medicine. 2015 Sep 15;8:303-8.
Di Pierro F, Colombo M, Zanvit A, Risso P, Rottoli AS. “Use of Streptococcus salivarius K12 in the prevention of streptococcal and viral pharyngotonsillitis in children.” Drug, Healthcare and Patient Safety. 2014 Feb 13;6:15-20.
Di Pierro F, Donato G, Fomia F, Adami T, Careddu D, Cassandro C, Albera R. “Preliminary pediatric clinical evaluation of the oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes and recurrent acute otitis media.” International Journal of General Medicine. 2012;5:991-7.
Wescombe PA, Hale JD, Heng NC, Tagg JR. “Developing oral probiotics from Streptococcus salivarius.” Future Microbiology. 2012 Dec;7(12):1355-71.
Burton JP, Cowley S, Simon RR, McKinney J, Wescombe PA, Tagg JR. “Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: a randomized, placebo-controlled, double-blind study.” Food and Chemical Toxicology. 2011 Sep;49(9):2356-64.
Burton JP, Chilcott CN, Wescombe PA, Tagg JR. “Extended Safety Data for the Oral Cavity Probiotic Streptococcus salivarius K12.” Probiotics and Antimicrobial Proteins. 2010 Oct;2(3):135-44.
Tagg JR. “Streptococcal Bacteriocin-Like Inhibitory Substances: Some Personal Insights into the Bacteriocin-Like Activities Produced by Streptococci Good and Bad.” Probiotics and Antimicrobial Proteins. 2009 Jun;1(1):60-6.
Burton JP, Wescombe PA, Moore CJ, Chilcott CN, Tagg JR. “Safety assessment of the oral cavity probiotic Streptococcus salivarius K12.” Applied and Environmental Microbiology. 2006 Apr;72(4):3050-3.
Burton JP, Chilcott CN, Moore CJ, Speiser G, Tagg JR. “A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters.” Journal of Applied Microbiology. 2006 Apr;100(4):754-64.
Burton JP, Chilcott CN, Tagg JR. “The rationale and potential for the reduction of oral malodour using Streptococcus salivarius probiotics.” Oral Diseases. 2005;11 Suppl 1:29-31.
Di Pierro F, Zanvit A, Nobili P, Risso P, Fornaini C. “Cariogram outcome after 90 days of oral treatment with Streptococcus salivarius M18 in children at high risk for dental caries: results of a randomized, controlled study.” Journal of Clinical, Cosmetic and Investigational Dentistry. 2015 Oct 3;7:107-13.
Scariya L, Nagarathna D.V, Varghese M. “Probiotics in Periodontal Therapy” International Journal of Pharma and Bio Sciences. 2015 Jan; 6(1): (P) 242 – 250.
Burton JP, Drummond BK, Chilcott CN, Tagg JR, Thomson WM, Hale JD, Wescombe PA. “Influence of the probiotic Streptococcus salivarius strain M18 on indices of dental health in children: a randomized double-blind, placebo-controlled trial.” Journal of Medical Microbiology. 2013 Jun;62(Pt 6):875-84.
Burton JP, Wescombe PA, Macklaim JM, et al. “Persistence of the oral probiotic Streptococcus salivarius M18 is dose dependent and megaplasmid transfer can augment their bacteriocin production and adhesion characteristics.” PLoS One. 2013;8(6):
Heng NC, Haji-Ishak NS, Kalyan A, et al. “Genome sequence of the bacteriocin producing oral probiotic Streptococcus salivarius strain M18.” Journal of Bacteriology. 2011;193:6402–6403.
Pradeep AR, Garg V, Raju A, Singh P. “Adjunctive Local Delivery of Aloe Vera Gel in Type 2 Diabetics With Chronic Periodontitis : A Randomized Controlled Clinical Trial.” Journal of Periodontology. 2015 Oct 8:1-10.
Kumar A, Sunkara MS, Pantareddy I, Sudhakar S. “Comparison of Plaque Inhibiting Efficacies of Aloe Vera and Propolis Tooth Gels: A Randomized PCR Study.” Journal of Clinical Diagnostic Research. 2015 Sep;9(9):ZC01-3.
Chandra Shekar BR, Nagarajappa R, Suma S, Thakur R. “Herbal extracts in oral health care - A review of the current scenario and its future needs.” Pharmacognosy Reviews. 2015 Jul-Dec;9(18):87-92.
Gupta RK, Gupta D, Bhaskar DJ, Yadav A, Obaid K, Mishra S. “Preliminary antiplaque efficacy of aloe vera mouthwash on 4 day plaque re-growth model: randomized control trial.” Ethiopian Journal of Health Sciences. 2014 Apr;24(2):139-44.
Karim B, Bhaskar DJ, Agali C, Gupta D, Gupta RK, Jain A, Kanwar A. “Effect of Aloe vera mouthwash on periodontal health: triple blind randomized control trial.” Journal of Oral Health and Dental Management. 2014 Mar;13(1):14-9.
Patil BA, Bhaskar HP, Pol JS, Sodhi A, Madhu AV. “Aloe vera as cure for lichen planus.” The New York State Dental Journal. 2013 Aug-Sep;79(5):65-8.
Pradeep AR, Agarwal E, Naik SB. Clinical and Microbiological Effects of Commercially Available Dentrifice Containing Aloe vera: A Randomized Controlled Clinical Trial. Journal of Periodontology. 2012 Jun;83(6):797-804.
Chandrahas B, Jayakumar A, Naveen A, Butchibabu K, Reddy PK, et al. A randomized, double-blind clinical study to assess the antiplaque and antigingivitis efficacy of Aloe vera mouth rinse. Journal of Indian Society of Periodontology. 2012; 16: 543-548.
Mansourian A, Momen-Heravi F, Saheb-Jamee M, Esfehani M, Khalilzadeh O, Momen-Beitollahi J. “Comparison of aloe vera mouthwash with triamcinolone acetonide 0.1% on oral lichen planus: a randomized double-blinded clinical trial.” The American Journal of the Medical Sciences. 2011 Dec;342(6):447-51.
de Oliveira SM, Torres TC, Pereira SL, Mota OM, Carlos MX. Effect of a dentifrice containing Aloe vera on plaque and gingivitis control. A double-blind clinical study in humans. Journal of Applied Oral Science. 2008 Jul-Aug;16(4):293-6.
Villalobos OJ, Salazar CR, Sánchez GR. Effect of a compound mouthwash Aloe vera in plaque and gingival inflammation. Acta Odontológica Venezolana. 2001; 39: 16-24.